Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2025 Earnings Call Transcript February 17, 2026 Halozyme Therapeutics, Inc.
Bausch Health Companies Inc. ( BHC) Q4 2025 Earnings Call February 18, 2026 5:00 PM EST Greetings, and welcome to the Bausch Health Fourth Quarter and Full Year 2025 Earnings Conference Call and ...
Q4 2025 Earnings Call February 18, 2026 3:30 AM ESTCompany ParticipantsGunilla Osswald - President & CEOJohanna Fälting ...
Fourth-Quarter Revenue of $994.2 Million and Full-Year Revenue of $4.02 Billion –– Fourth-Quarter GAAP Loss per Share of $(5.62) and Non-GAAP Earnings per Share of $2.39 –– Full-Year GAAP Loss per ...
In his report, Senator Bill Cassidy suggested a slate of changes to the FDA to support broader drug access and to reduce ...
Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This is important in the context of low-resourced health settings, Africa's focus ...
After decades, scientists have finally pieced together the 23-step biosynthetic pathway to produce this cancer drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results